stars 1 stars 2 stars 3

Fluotek is a pioneer in breakthrough biotechnologies focusing on changing the global healthcare landscape. Unlike other pharmaceutical or diagnostic organizations, the combination of biotherapeutics and diagnostics under one brand offers Fluotek a more complete perspective when tackling the current medical problems. We define ourselves as a leader on the frontier of translating top technologies into therapeutic and diagnostic products. The core pipeline spans the spectrum of regenerative medicine, oncology, immunology, metabolic syndrome, blood-testing, and various medical devices, all of which come from our R&D center with the world-leading platforms and instruments. Since 2016, Fluotek continues to explore better ways to diagnose, treat, cure, and ultimately prevent diseases. Fluotek's achievements are inseparable from our elite employees who dedicated their careers to helping lives, no matter their backgrounds and positions. Our current and future commercialized products and services will make lives better, and this common goal will guide us to rapidly becoming a world leader in the healthcare industry.

Fluotek Questions

The Fluotek annual revenue was $116.9 million in 2026.

Yang Yang is the CEO of Fluotek.

23 people are employed at Fluotek.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users